New study aims to fill gap in breast cancer treatment for elderly women
NCT ID NCT07399808
First seen Feb 17, 2026 · Last updated May 17, 2026 · Updated 19 times
Summary
This study looks at how older women (70+) with breast cancer handle CDK4/6 inhibitors, a common targeted therapy. Researchers will track side effects and compare them to younger patients. The goal is to provide better treatment guidance for this often-underrepresented group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fondazione IRCCS Policlinico San Matteo di Pavia
RECRUITINGPavia, Pavia, 27100, Italy
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.